The independent association of mean platelet volume with overall survival in multiple myeloma - PubMed (original) (raw)

The independent association of mean platelet volume with overall survival in multiple myeloma

Qiang Zhuang et al. Oncotarget. 2016.

Abstract

We retrospectively analyzed the association between mean platelet volume (MPV) and prognosis in 62 newly diagnosed multiple myeloma (MM) patients. The associations between MPV and clinical characteristics were assessed. The log-rank test and the Cox proportional hazards model were used to evaluate the effect of MPV on survival. A MPV value of 8.50 fl was considered to be the optimal cut-off value for prognosis. MPV was associated with IgA isotype (P=0.012), serum creatinine concentration > 176.8 μmol/L (P=0.025) and IgH rearrangement (P=0.008). The log-rank test demonstrated that patients with low MPV experienced a shorter overall survival (OS) (P=0.0397). The multivariate analysis demonstrated that low MPV was an independent prognostic factor for OS [hazard ratio (HR)=2.44, P=0.026]. Therefore, we demonstrated that low MPV predicted an unfavorable prognosis in patients with MM.

Keywords: mean platelet volume; multiple myeloma; prognosis; survival.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interests.

Figures

Figure 1

Figure 1. Kaplan-Meier analysis of overall survival of all the patients included in this study stratified by mean platelet volume (MPV; ≤8.50 vs. >8.50 fl)

References

    1. Kristinsson SY, Fears TR, Gridley G, Turesson I, Mellqvist UH, Bjorkholm M, Landgren O. Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma. Blood. 2008;112:3582–3586. - PMC - PubMed
    1. Kristinsson SY, Pfeiffer RM, Bjorkholm M, Goldin LR, Schulman S, Blimark C, Mellqvist UH, Wahlin A, Turesson I, Landgren O. Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study. Blood. 2010;115:4991–4998. - PMC - PubMed
    1. Kristinsson SY. Thrombosis in multiple myeloma. Hematology / the Education Program of the American Society of Hematology American Society of Hematology Education Program. 2010;2010:437–444. - PubMed
    1. Leebeek FW, Kruip MJ, Sonneveld P. Risk and management of thrombosis in multiple myeloma. Thrombosis research. 2012;129:S88–92. - PubMed
    1. Johnson DC, Corthals S, Ramos C, Hoering A, Cocks K, Dickens NJ, Haessler J, Goldschmidt H, Child JA, Bell SE, Jackson G, Baris D, Rajkumar SV, et al. Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping. Blood. 2008;112:4924–4934. - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources